Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/42149Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chong, Clara | - |
| dc.date.accessioned | 2021-04-27T02:13:32Z | - |
| dc.date.available | 2021-04-27T02:13:32Z | - |
| dc.date.issued | 2021-04-26 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/42149 | - |
| dc.description | page 3 | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | The New Paper | en_US |
| dc.subject | Virus | en_US |
| dc.subject | Medical awareness | en_US |
| dc.title | Study: Throat spray, anti-malaria drug reduce Covid risk | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Newspaper Clippings | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| April 26, 2021 pg 3.pdf | Study: Throat spray, anti-malaria drug reduce Covid risk | 112 kB | Adobe PDF | View/Open |
Items in QC LIBROS are protected by copyright, with all rights reserved, unless otherwise indicated.